VIEMED HEALTHCARE, INC. (VMD) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 47.89M USD | Liabilities, Current |
| Cash and equivalents | 10.68M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 32.23M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 5.27M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $47.89M | $10.68M | (m) | $32.23M | $5.27M | (m) |
| 2026-03-31 | (m) | $40.71M | $9.76M | (m) | $31.18M | $5.18M | (m) |
| 2025-12-31 | (m) | $41.06M | $13.50M | (m) | $25.59M | $5.05M | (m) |
| 2025-09-30 | (m) | $44.19M | $11.12M | (m) | $27.41M | $5.27M | (m) |
| 2025-06-30 | (m) | $37.27M | $20.02M | (m) | $26.55M | $4.32M | (m) |
| 2025-03-31 | (m) | $35.49M | $10.16M | (m) | $26.79M | $4.51M | (m) |
| 2024-12-31 | (m) | $37.33M | $17.54M | (m) | $24.91M | $4.32M | (m) |
| 2024-09-30 | (m) | $36.44M | $11.35M | (m) | $27.05M | $4.31M | (m) |
| 2024-06-30 | (m) | $31.48M | $8.81M | (m) | $27.06M | $4.42M | (m) |
| 2024-03-31 | (m) | $30.12M | $7.31M | (m) | $24.48M | $4.35M | (m) |
| 2023-12-31 | (m) | $32.12M | $12.84M | (m) | $18.45M | $4.63M | (m) |
| 2023-09-30 | (m) | $31.55M | $10.08M | (m) | $17.93M | $4.67M | (m) |
| 2023-06-30 | (m) | $31.57M | $10.22M | (m) | $17.89M | $4.48M | (m) |
| 2023-03-31 | (m) | $23.42M | $23.54M | (m) | $16.32M | $3.45M | (m) |
| 2022-12-31 | (m) | $18.86M | $16.91M | (m) | $15.38M | $3.57M | (m) |
| 2022-09-30 | (m) | $20.56M | $21.48M | (m) | $14.98M | $3.18M | (m) |
| 2022-06-30 | (m) | $17.86M | $21.92M | (m) | $14.29M | $2.85M | (m) |
| 2022-03-31 | (m) | $17.73M | $29.25M | (m) | $13.60M | $2.50M | (m) |
| 2021-12-31 | (m) | $17.81M | $28.41M | (m) | $12.82M | $2.46M | (m) |
| 2021-09-30 | (m) | $20.20M | $26.87M | (m) | $12.70M | $2.62M | (m) |
| 2021-06-30 | (m) | $18.32M | $31.15M | (m) | $12.13M | $2.56M | (m) |
| 2021-03-31 | (m) | $21.86M | $31.10M | (m) | $13.28M | $2.22M | (m) |
| 2020-12-31 | (m) | $23.02M | $30.98M | (m) | $12.37M | $2.31M | (m) |
| 2020-09-30 | (m) | $30.35M | $32.40M | (m) | $11.49M | $2.76M | (m) |
| 2020-06-30 | (m) | $31.77M | $29.71M | (m) | $11.03M | $6.58M | (m) |
| 2020-03-31 | (m) | $26.15M | $8.41M | (m) | $15.44M | $1.78M | (m) |
| 2019-12-31 | (m) | $25.91M | $13.36M | (m) | $11.53M | $1.36M | (m) |
| 2019-09-30 | (m) | $23.20M | $12.63M | (m) | $11.73M | $1.27M | (m) |
| 2019-06-30 | (m) | $24.11M | $7.69M | (m) | $12.80M | $3.71M | (m) |
| 2019-03-31 | (m) | $21.68M | $7.41M | (m) | $11.67M | $3.62M | (m) |
| 2018-12-31 | (m) | $16.98M | $10.41M | (m) | $8.84M | $2.89M | (m) |
| 2018-09-30 | (m) | $17.19M | $10.17M | (m) | $8.39M | $2.38M | (m) |
| 2018-06-30 | (m) | $15.46M | $8.55M | (m) | $7.86M | $1.94M | (m) |
| 2018-03-31 | (m) | $14.61M | $4.63M | (m) | $10.69M | $1.96M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |